21 February 2018
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics determined the use of proton pump inhibitors and H2-receptor antagonists in the year before anti-reflux surgery.
Guidelines recommend that patients with gastro-oesophageal reflux disease are adequately treated
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors